Industry: Consumer Goods
Published Date: 2024-01-05
Pages: 124 Pages
Report ld: 2151579
Request Sample
Customized Report
The global market for HMO Formula was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for HMO Formula was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for HMO Formula was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for HMO Formula was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of HMO Formula include Abbott, Wyeth, Nestlé, Feihe, Junlebao, Humana, Mead Johnson, Walgreen and Yeeper, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for HMO Formula, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of HMO Formula by region & country, by Type, and by Application.
The HMO Formula market size, estimations, and forecasts are provided in terms of sales volume (K Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HMO Formula.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of HMO Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of HMO Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of HMO Formula in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 HMO Formula Product Introduction
1.2 Global HMO Formula Market Size Forecast
1.2.1 Global HMO Formula Sales Value (2019-2030)
1.2.2 Global HMO Formula Sales Volume (2019-2030)
1.2.3 Global HMO Formula Sales Price (2019-2030)
1.3 HMO Formula Market Trends & Drivers
1.3.1 HMO Formula Industry Trends
1.3.2 HMO Formula Market Drivers & Opportunity
1.3.3 HMO Formula Market Challenges
1.3.4 HMO Formula Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global HMO Formula Players Revenue Ranking (2023)
2.2 Global HMO Formula Revenue by Company (2019-2024)
2.3 Global HMO Formula Players Sales Volume Ranking (2023)
2.4 Global HMO Formula Sales Volume by Company Players (2019-2024)
2.5 Global HMO Formula Average Price by Company (2019-2024)
2.6 Key Manufacturers HMO Formula Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers HMO Formula Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of HMO Formula
2.9 HMO Formula Market Competitive Analysis
2.9.1 HMO Formula Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by HMO Formula Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HMO Formula as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Powder
3.1.2 Liquid Concentrate
3.1.3 Ready-to-Feed
3.2 Global HMO Formula Sales Value by Type
3.2.1 Global HMO Formula Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global HMO Formula Sales Value, by Type (2019-2030)
3.2.3 Global HMO Formula Sales Value, by Type (%) (2019-2030)
3.3 Global HMO Formula Sales Volume by Type
3.3.1 Global HMO Formula Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global HMO Formula Sales Volume, by Type (2019-2030)
3.3.3 Global HMO Formula Sales Volume, by Type (%) (2019-2030)
3.4 Global HMO Formula Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Online Sales
4.1.2 Offline Sales
4.2 Global HMO Formula Sales Value by Application
4.2.1 Global HMO Formula Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global HMO Formula Sales Value, by Application (2019-2030)
4.2.3 Global HMO Formula Sales Value, by Application (%) (2019-2030)
4.3 Global HMO Formula Sales Volume by Application
4.3.1 Global HMO Formula Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global HMO Formula Sales Volume, by Application (2019-2030)
4.3.3 Global HMO Formula Sales Volume, by Application (%) (2019-2030)
4.4 Global HMO Formula Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global HMO Formula Sales Value by Region
5.1.1 Global HMO Formula Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global HMO Formula Sales Value by Region (2019-2024)
5.1.3 Global HMO Formula Sales Value by Region (2025-2030)
5.1.4 Global HMO Formula Sales Value by Region (%), (2019-2030)
5.2 Global HMO Formula Sales Volume by Region
5.2.1 Global HMO Formula Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global HMO Formula Sales Volume by Region (2019-2024)
5.2.3 Global HMO Formula Sales Volume by Region (2025-2030)
5.2.4 Global HMO Formula Sales Volume by Region (%), (2019-2030)
5.3 Global HMO Formula Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America HMO Formula Sales Value, 2019-2030
5.4.2 North America HMO Formula Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe HMO Formula Sales Value, 2019-2030
5.5.2 Europe HMO Formula Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific HMO Formula Sales Value, 2019-2030
5.6.2 Asia Pacific HMO Formula Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America HMO Formula Sales Value, 2019-2030
5.7.2 South America HMO Formula Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa HMO Formula Sales Value, 2019-2030
5.8.2 Middle East & Africa HMO Formula Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions HMO Formula Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions HMO Formula Sales Value
6.2.1 Key Countries/Regions HMO Formula Sales Value, 2019-2030
6.2.2 Key Countries/Regions HMO Formula Sales Volume, 2019-2030
6.3 United States
6.3.1 United States HMO Formula Sales Value, 2019-2030
6.3.2 United States HMO Formula Sales Value by Type (%), 2023 VS 2030
6.3.3 United States HMO Formula Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe HMO Formula Sales Value, 2019-2030
6.4.2 Europe HMO Formula Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe HMO Formula Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China HMO Formula Sales Value, 2019-2030
6.5.2 China HMO Formula Sales Value by Type (%), 2023 VS 2030
6.5.3 China HMO Formula Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan HMO Formula Sales Value, 2019-2030
6.6.2 Japan HMO Formula Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan HMO Formula Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea HMO Formula Sales Value, 2019-2030
6.7.2 South Korea HMO Formula Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea HMO Formula Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia HMO Formula Sales Value, 2019-2030
6.8.2 Southeast Asia HMO Formula Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia HMO Formula Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India HMO Formula Sales Value, 2019-2030
6.9.2 India HMO Formula Sales Value by Type (%), 2023 VS 2030
6.9.3 India HMO Formula Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott HMO Formula Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Abbott HMO Formula Product Offerings
7.1.5 Abbott Recent Development
7.2 Wyeth
7.2.1 Wyeth Company Information
7.2.2 Wyeth Introduction and Business Overview
7.2.3 Wyeth HMO Formula Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Wyeth HMO Formula Product Offerings
7.2.5 Wyeth Recent Development
7.3 Nestlé
7.3.1 Nestlé Company Information
7.3.2 Nestlé Introduction and Business Overview
7.3.3 Nestlé HMO Formula Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Nestlé HMO Formula Product Offerings
7.3.5 Nestlé Recent Development
7.4 Feihe
7.4.1 Feihe Company Information
7.4.2 Feihe Introduction and Business Overview
7.4.3 Feihe HMO Formula Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Feihe HMO Formula Product Offerings
7.4.5 Feihe Recent Development
7.5 Junlebao
7.5.1 Junlebao Company Information
7.5.2 Junlebao Introduction and Business Overview
7.5.3 Junlebao HMO Formula Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Junlebao HMO Formula Product Offerings
7.5.5 Junlebao Recent Development
7.6 Humana
7.6.1 Humana Company Information
7.6.2 Humana Introduction and Business Overview
7.6.3 Humana HMO Formula Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Humana HMO Formula Product Offerings
7.6.5 Humana Recent Development
7.7 Mead Johnson
7.7.1 Mead Johnson Company Information
7.7.2 Mead Johnson Introduction and Business Overview
7.7.3 Mead Johnson HMO Formula Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Mead Johnson HMO Formula Product Offerings
7.7.5 Mead Johnson Recent Development
7.8 Walgreen
7.8.1 Walgreen Company Information
7.8.2 Walgreen Introduction and Business Overview
7.8.3 Walgreen HMO Formula Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Walgreen HMO Formula Product Offerings
7.8.5 Walgreen Recent Development
7.9 Yeeper
7.9.1 Yeeper Company Information
7.9.2 Yeeper Introduction and Business Overview
7.9.3 Yeeper HMO Formula Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Yeeper HMO Formula Product Offerings
7.9.5 Yeeper Recent Development
7.10 Yili
7.10.1 Yili Company Information
7.10.2 Yili Introduction and Business Overview
7.10.3 Yili HMO Formula Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Yili HMO Formula Product Offerings
7.10.5 Yili Recent Development
8 Industry Chain Analysis
8.1 HMO Formula Industrial Chain
8.2 HMO Formula Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 HMO Formula Sales Model
8.5.2 Sales Channel
8.5.3 HMO Formula Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global HMO Formula market is projected to grow from US$ 4200 million in 2025 to US$ 8633 million by 2032, at a CAGR of 11.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-31
Pages: 136
USD 4900.00
(Single User License)
The global HMO Formula market size was US$ 4200 million in 2025 and is forecast to reach a readjusted size of US$ 8633 million by 2032 with a CAGR of 11.0% during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 80
USD 4250.00
(Single User License)
The global market for HMO Formula was estimated to be worth US$ 4200 million in 2025 and is projected to reach US$ 8633 million, growing at a CAGR of 11.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 107
USD 3950.00
(Single User License)
The global HMO Formula market was valued at US$ 4200 million in 2025 and is anticipated to reach US$ 8633 million by 2032, at a CAGR of 11.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 110
USD 2900.00
(Single User License)
The global HMO Formula market is projected to grow from US$ 3900 million in 2024 to US$ 7856 million by 2031, at a CAGR of 11.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-02
Pages: 146
USD 4900.00
(Single User License)
The global market for HMO Formula was valued at US$ 3900 million in the year 2024 and is projected to reach a revised size of US$ 7856 million by 2031, growing at a CAGR of 11.0% during the forecast period.
Published Date: 2025-03-10
Pages: 86
USD 2900.00
(Single User License)
The global market for HMO Formula was estimated to be worth US$ 3900 million in 2024 and is forecast to a readjusted size of US$ 7856 million by 2031 with a CAGR of 11.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 100
USD 3950.00
(Single User License)
The global HMO Formula market size was US$ 3900 million in 2024 and is forecast to a readjusted size of US$ 7856 million by 2031 with a CAGR of 11.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 77
USD 4250.00
(Single User License)
The global HMO Formula market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-05
Pages: 93
USD 2900.00
(Single User License)
The global HMO Formula market is projected to grow from US$ 4200 million in 2025 to US$ 8633 million by 2032, at a CAGR of 11.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-31
Pages: 136
The global HMO Formula market size was US$ 4200 million in 2025 and is forecast to reach a readjusted size of US$ 8633 million by 2032 with a CAGR of 11.0% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 80
The global market for HMO Formula was estimated to be worth US$ 4200 million in 2025 and is projected to reach US$ 8633 million, growing at a CAGR of 11.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 107
The global HMO Formula market was valued at US$ 4200 million in 2025 and is anticipated to reach US$ 8633 million by 2032, at a CAGR of 11.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 110
The global HMO Formula market is projected to grow from US$ 3900 million in 2024 to US$ 7856 million by 2031, at a CAGR of 11.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-02
Pages: 146
The global market for HMO Formula was valued at US$ 3900 million in the year 2024 and is projected to reach a revised size of US$ 7856 million by 2031, growing at a CAGR of 11.0% during the forecast period.
Published: 2025-03-10
Pages: 86
The global market for HMO Formula was estimated to be worth US$ 3900 million in 2024 and is forecast to a readjusted size of US$ 7856 million by 2031 with a CAGR of 11.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 100
The global HMO Formula market size was US$ 3900 million in 2024 and is forecast to a readjusted size of US$ 7856 million by 2031 with a CAGR of 11.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 77
The global HMO Formula market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-05
Pages: 93
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now